Showing results (111-120 of 9,974) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|November 8, 2001
A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitorsY HonmaLeukemia & Lymphoma|November 8, 2001
Intravenous bolus topotecan in patients with myelodysplastic syndromeK Seiter, D Liu, E J Feldman, et al.Leukemia & Lymphoma|November 8, 2001
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update resultsP L Zinzani, V Stefoni, M Tani, et al.Leukemia & Lymphoma|November 9, 2001
Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expressionB Gu, L P Dao, J WileyLeukemia & Lymphoma|November 9, 2001
Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook FB J ChenLeukemia & Lymphoma|November 9, 2001
Outpatient supportive care following chemotherapy for acute myeloblastic leukemiaD S Allan, R Buckstein, K R ImrieLeukemia & Lymphoma|November 9, 2001
Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patientsF Hartmann, G Jacobs, H Gotto, et al.Leukemia & Lymphoma|November 9, 2001
Treatment of post-transplanted, relapsed patients with hematological malignancies by infusion of HLA-matched, allogeneic-dendritic cells (DCs) pulsed with irradiated tumor cells and primed T cellsS Fujii, K Shimizu, K Fujimoto, et al.Leukemia & Lymphoma|May 10, 2002
Angiogenic and lymphangiogenic molecules in hematological malignanciesArto Orpana, Petri SalvenLeukemia & Lymphoma|May 10, 2002
Bendamustine mitoxantrone and rituximab (BMR): a new effective regimen for refractory or relapsed indolent lymphomasRudolf Weide, Jochen Heymanns, Annette Gores, et al.Pageof 998